| Leukemic blasts in transformed JAK2-V617F–positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation. A Theocharides, M Boissinot, F Girodon, R Garand, SS Teo, E Lippert, ... Blood, The Journal of the American Society of Hematology 110 (1), 375-379, 2007 | 383 | 2007 |
| The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera E Lippert, M Boissinot, R Kralovics, F Girodon, I Dobo, V Praloran, ... Blood 108 (6), 1865-1867, 2006 | 329 | 2006 |
| The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera E Lippert, M Boissinot, R Kralovics, F Girodon, I Dobo, V Praloran, ... Blood 108 (6), 1865-1867, 2006 | 329 | 2006 |
| Cytokines as biomarkers in rheumatoid arthritis A Burska, M Boissinot, F Ponchel Mediators of inflammation 2014, 2014 | 266 | 2014 |
| Autoantibodies to posttranslational modifications in rheumatoid arthritis AN Burska, L Hunt, M Boissinot, R Strollo, BJ Ryan, E Vital, A Nissim, ... Mediators of Inflammation 2014, 2014 | 121 | 2014 |
| Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis M Boissinot, E Lippert, F Girodon, I Dobo, M Fouassier, C Masliah, ... Blood 108 (9), 3223-3224, 2006 | 84 | 2006 |
| The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS) M Boissinot, R Garand, M Hamidou, S Hermouet Blood 108 (5), 1781-1782, 2006 | 78 | 2006 |
| Prediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signature J Hayes, H Thygesen, C Tumilson, A Droop, M Boissinot, TA Hughes, ... Molecular oncology 9 (3), 704-714, 2015 | 68 | 2015 |
| An immunological biomarker to predict MTX response in early RA F Ponchel, V Goëb, R Parmar, Y El-Sherbiny, M Boissinot, J El Jawhari, ... Annals of the rheumatic diseases 73 (11), 2047-2053, 2014 | 68 | 2014 |
| Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts … M Boissinot, C Cleyrat, M Vilaine, Y Jacques, I Corre, S Hermouet Oncogene 30 (8), 990-1001, 2011 | 68 | 2011 |
| Induction of differentiation and apoptosis in leukaemic cell lines by the novel benzamide family histone deacetylase 2 and 3 inhibitor MI-192 M Boissinot, M Inman, A Hempshall, SR James, JH Gill, P Selby, ... Leukemia research 36 (10), 1304-1310, 2012 | 53 | 2012 |
| A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia MW Drummond, C Pocock, M Boissinot, J Mills, J Brown, P Cauchy, ... Leukemia 28 (7), 1570-1572, 2014 | 40 | 2014 |
| The Hepatocyte Growth Factor (HGF)/met axis: a neglected target in the treatment of chronic myeloproliferative neoplasms? M Boissinot, M Vilaine, S Hermouet Cancers 6 (3), 1631-1669, 2014 | 37 | 2014 |
| JAK2 mutation and disease phenotype: a double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather … C Cleyrat, J Jelinek, F Girodon, M Boissinot, T Ponge, JL Harousseau, ... Leukemia 24 (5), 1069-1073, 2010 | 35 | 2010 |
| The human IL-3/granulocyte-macrophage colony-stimulating factor locus is epigenetically silent in immature thymocytes and is progressively activated during T cell development F Mirabella, EW Baxter, M Boissinot, SR James, PN Cockerill The Journal of Immunology 184 (6), 3043-3054, 2010 | 31 | 2010 |
| Erythropoietin-independent erythroid colony formation by bone marrow progenitors exposed to interleukin-11 and interleukin-8 I Corre-Buscail, D Pineau, M Boissinot, S Hermouet Experimental Hematology 33 (11), 1299-1308, 2005 | 18 | 2005 |
| Identification of transcriptional targets of GSK3 involved in glioblastoma invasion A Bruning-Richardson, A Droop, D Tams, M Boissinot, J Hayes, V Cheng, ... Neuro-Oncology 20 (suppl_1), i26-i26, 2018 | 7 | 2018 |
| Profiling cytotoxic microRNAs in pediatric and adult glioblastoma cells by high-content screening, identification, and validation of miR-1300 M Boissinot, H King, M Adams, J Higgins, G Shaw, TA Ward, LP Steele, ... Oncogene 39 (30), 5292-5306, 2020 | 6 | 2020 |
| Myeloid Blasts in Transformed JAK2-V617F Positive Myeloproliferative Disorders Are Frequently Negative for the JAK2-V617F Mutation. A Theocharides, M Boissinot, R Garand, F Girodon, SS Teo, E Lippert, ... Blood, The Journal of the American Society of Hematology 108 (11), 375-375, 2006 | 6 | 2006 |
| GSK-3 inhibition is cytotoxic in glioma stem cells through centrosome destabilization and enhances the effect of radiotherapy in orthotopic models A Brüning-Richardson, GC Shaw, D Tams, T Brend, H Sanganee, ... Cancers 13 (23), 5939, 2021 | 4 | 2021 |
